Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53
- 27 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 334 (1) , 223-230
- https://doi.org/10.1016/j.bbrc.2005.06.073
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Alterations in Activating Protein 1 Composition Correlate with Phenotypic Differentiation Changes Induced by Resveratrol in Human MelanomaMolecular Pharmacology, 2005
- Anti‐proliferative and proapoptotic effects of (−)‐epigallocatechin‐3‐gallate on human melanoma: Possible implications for the chemoprevention of melanomaInternational Journal of Cancer, 2004
- Deficiency of NRH:Quinone Oxidoreductase 2 Increases Susceptibility to 7,12-Dimethylbenz( a )anthracene and Benzo( a )pyrene-Induced Skin CarcinogenesisCancer Research, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Wine and resveratrol: mechanisms of cancer prevention?European Journal Of Cancer Prevention, 2003
- Chemoprevention: an essential approach to controlling cancerNature Reviews Cancer, 2002
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- The incidence of malignant melanoma in the United States: Issues as we approach the 21st centuryJournal of the American Academy of Dermatology, 1996
- Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonistCancer Letters, 1995
- Differential Expression and Mutation of nme Genes in Autologous Cultured Human Melanoma Cells with Different Metastatic PotentialsBiochemical and Biophysical Research Communications, 1995